Structural and functional characterization of factor XII.
In this article we have reviewed the current knowledge regarding the involvement of Factor XII in contact activation. Clearly in the past decade an overwhelming amount of data and hypotheses have been published regarding the central role of this zymogen in the initiation and further propagation of contact activation reactions. Therefore we feel that it will be helpful to conclude this article with a figure that summarizes those interactions and reactions that are generally believed to reflect the major molecular events occurring during surface-dependent contact activation. The contact factors are capable of very efficient interation with each other, provided a suitable negatively charged surface is present. Such surfaces are thought to stimulate the interactions between the contact factors through binding of the proteins and thus bringing the proteins together. Factor XII readily binds to the negatively charged surface, but for the binding of prekallikrein and Factor XI, the cofactor HMW kininogen is likely to be necessary. Bound at the surface, the zymogens Factor XII and prekallikrein are thought to be involved in a so-called reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to Factor XIIa. The formation of Factor XIIa is further promoted by the fact that surface-bound Factor XII is likely more susceptible to proteolytic cleavage and by the fact that the activated Factor XIIa is capable of auto-activating its own zymogen Factor XII. However, the latter effect, although undoubtedly contributing to the formation of Factor XIIa at the surface, seems to be of less importance than the reciprocal activation mechanism. This is underscored by the fact that Factor XII activation is rather slow in prekallikrein-deficient plasma. Surface-bound Factor XIIa is then responsible for the activation of Factor XI to Factor XIa, thereby propagating the initial trigger. Presumably, Factor XIa must leave the surface in order to be able to become involved in the activation of blood coagulation Factor IX.
D000595:Amino Acid Sequence; D000990:Antithrombin III / Q000502:physiology; D001777:Blood Coagulation; D003174:Complement C1 Inactivator Proteins / Q000502:physiology; D004789:Enzyme Activation; D005172:Factor XI / Q000378:metabolism; D005174:Factor XII / Q000032:analysis / Q000302:isolation & purification / Q000502:physiology*; D015956:Factor XIIa; D005342:Fibrinolysis; D006801:Humans; D007610:Kallikreins / Q000502:physiology; D007700:Kinetics; D008970:Molecular Weight; D010446:Peptide Fragments / Q000502:physiology; D011288:Prekallikrein / Q000378:metabolism
D003174:Complement C1 Inactivator Proteins; D010446:Peptide Fragments; D000990:Antithrombin III; D005174:Factor XII; D005172:Factor XI; D011288:Prekallikrein; D007610:Kallikreins; D015956:Factor XIIa